Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial 9vol 125, pg 1301, 2019)

被引：0
|
作者：
Vink, P.
Mingorance, Delgado, I
Alonso, Maximiano C.
机构：
来源：
CANCER | 2020年 / 126卷 / 12期
关键词：
D O I：
10.1002/cncr.32842
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2941 / 2941
页数：1
相关论文
共 11 条
  • [1] Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial
    Vink, Peter
    Delgado Mingorance, Ignacio
    Maximiano Alonso, Constanza
    Rubio-Viqueira, Belen
    Jung, Kyung Hae
    Rodriguez Moreno, Juan Francisco
    Grande, Enrique
    Marrupe Gonzalez, David
    Lowndes, Sarah
    Puente, Javier
    Kristeleit, Hartmut
    Farrugia, David
    McNeil, Shelly A.
    Campora, Laura
    Di Paolo, Emmanuel
    El Idrissi, Mohamed
    Godeaux, Olivier
    Lopez-Fauqued, Marta
    Salaun, Bruno
    Heineman, Thomas C.
    Oostvogels, Lidia
    CANCER, 2019, 125 (08) : 1301 - 1312
  • [2] Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial
    Vink, Peter
    Ramon Torrell, Josep Maria
    Sanchez Fructuoso, Ana
    Kim, Sung-Joo
    Kim, Sang-Il
    Zaltzman, Jeff
    Ortiz, Fernanda
    Campistol Plana, Josep Maria
    Fernandez Rodriguez, Ana Maria
    Rebollo Rodrigo, Henar
    Campins Marti, Magda
    Perez, Rafael
    Gonzalez Roncero, Francisco Manuel
    Kumar, Deepali
    Chiang, Yang-Jen
    Doucette, Karen
    Pipeleers, Lissa
    Aguera Morales, Maria Luisa
    Luisa Rodriguez-Ferrero, Maria
    Secchi, Antonio
    McNeil, Shelly A.
    Campora, Laura
    Di Paolo, Emmanuel
    El Idrissi, Mohamed
    Lopez-Fauqued, Marta
    Salaun, Bruno
    Heineman, Thomas C.
    Oostvogels, Lidia
    Rossana, Caldara
    Mario, Carmellini
    Yen-Ta, Chen
    Giacomo, Garibotto
    Esther, Gonzalez Montes
    Nada, Kanaan
    Dirk, Kuypers
    Cheng-Chia, Lin
    Umberto, Maggiore
    Pavel, Navratil
    Arjan, Van der Tol
    Ignacio, Villate Navarro Jose
    Bice, Virgilio
    Ming-Ju, Wu
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (02) : 181 - 190
  • [3] Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial (vol 36, pg 4278, 2018)
    Marechal, Celine
    Lal, Himal
    Poder, Airi
    Ferguson, Murdo
    Enweonye, Igwebuike
    Heineman, Thomas C.
    Herve, Caroline
    Rheault, Paul
    Talli, Jaak
    Wauters, Dominique
    Oostvogels, Lidia
    VACCINE, 2019, 37 (09) : 1252 - 1253
  • [4] The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy
    Lasagna, Angioletta
    Mele, Dalila
    Bergami, Federica
    Alaimo, Domiziana
    Dauccia, Chiara
    Alessio, Nicolo
    Comolli, Giuditta
    Pasi, Francesca
    Muzzi, Alba
    Novelli, Viola
    Baldanti, Fausto
    Pedrazzoli, Paolo
    Cassaniti, Irene
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
  • [5] Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial
    Marechal, Celine
    Lal, Himal
    Poder, Airi
    Ferguson, Murdo
    Enweonye, Igwebuike
    Heineman, Thomas C.
    Herve, Caroline
    Rheault, Paul
    Talli, Jaak
    Wauters, Dominique
    Oostvogels, Lidia
    VACCINE, 2018, 36 (29) : 4278 - 4286
  • [6] Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised clinical trials and post-hoc efficacy analysis (vol 19, pg 988, 2019)
    Dagnew, A. F.
    Ilhan, A.
    Lee, W-S
    LANCET INFECTIOUS DISEASES, 2020, 20 (01): : E1 - E1
  • [7] Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial (vol 322, pg 123, 2019)
    Bastidas, A.
    de la Serna, J.
    El Idrissi, M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (08): : 785 - 785
  • [8] No Immunological Interference or Safety Concerns When Adjuvanted Recombinant Zoster Vaccine Is Coadministered With a Coronavirus Disease 2019 mRNA-1273 Booster Vaccine in Adults Aged 50 Years and Older: A Randomized Trial
    Naficy, Abdi
    Kuxhausen, Adrienne
    Pirrotta, Paola
    Leav, Brett
    Miller, Jacqueline
    Anteyi, Kate
    Danier, Jasur
    Breuer, Thomas
    Mwakingwe-Omari, Agnes
    CLINICAL INFECTIOUS DISEASES, 2023, : 1238 - 1246
  • [9] Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial (vol 19, pg 1001, 2019)
    Mullane, K. M.
    Morrison, V. A.
    Camacho, L. H.
    LANCET INFECTIOUS DISEASES, 2019, 19 (10): : E337 - E337
  • [10] Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine-A Study Protocol (vol 9, 761655, 2022)
    Chopra, Arvind
    Chavan-Gautam, Preeti
    Tillu, Girish
    Saluja, Manjit
    Borse, Swapnil
    Sarmukaddam, Sanjeev
    Chaudhuri, Susmita
    Rao, B. C. S.
    Yadav, Babita
    Srikanth, Narayanam
    Patwardhan, Bhushan
    FRONTIERS IN MEDICINE, 2022, 9
12